Allergan Sales, LLC recalls TAZORAC (tazarotene) Gel 0.05%, Rx only, For Dermatologic Use Only, Not for Ophthalmic Use, packaged in a) 30 g tubes (…
- Recall date
- June 30, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0099-2017
- FDA classification
- Class II
- Brand / firm
- Allergan Sales, LLC
- Sold / distributed
- Nationwide
Why it was recalled
Failed Content Uniformity Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
TAZORAC (tazarotene) Gel 0.05%, Rx only, For Dermatologic Use Only, Not for Ophthalmic Use, packaged in a) 30 g tubes (NDC: 0023-8335-03, UPC: 300238335036) and b)100 g tubes,(NDC: 0023-8335-10, UPC: 300238335104), Manufactured by: Allergan Inc., Irvine, CA 92512.
Get recall alerts
Free email alert whenever Allergan Sales, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Allergan Sales, LLC